Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 14 |
NetGPI | no | yes: 0, no: 14 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 1 |
GO:0042995 | cell projection | 2 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 1 |
Related structures:
AlphaFold database: A0A3S7X261
Term | Name | Level | Count |
---|---|---|---|
GO:0006807 | nitrogen compound metabolic process | 2 | 15 |
GO:0008152 | metabolic process | 1 | 15 |
GO:0019538 | protein metabolic process | 3 | 15 |
GO:0036211 | protein modification process | 4 | 15 |
GO:0043170 | macromolecule metabolic process | 3 | 15 |
GO:0043412 | macromolecule modification | 4 | 15 |
GO:0044238 | primary metabolic process | 2 | 15 |
GO:0071704 | organic substance metabolic process | 2 | 15 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 15 |
GO:0000226 | microtubule cytoskeleton organization | 3 | 1 |
GO:0006996 | organelle organization | 4 | 1 |
GO:0007010 | cytoskeleton organization | 5 | 1 |
GO:0007017 | microtubule-based process | 2 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016043 | cellular component organization | 3 | 1 |
GO:0018095 | protein polyglutamylation | 7 | 1 |
GO:0018193 | peptidyl-amino acid modification | 5 | 1 |
GO:0018200 | peptidyl-glutamic acid modification | 6 | 1 |
GO:0071840 | cellular component organization or biogenesis | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 7 |
GO:0016874 | ligase activity | 2 | 7 |
GO:0005488 | binding | 1 | 1 |
GO:0005515 | protein binding | 2 | 1 |
GO:0008092 | cytoskeletal protein binding | 3 | 1 |
GO:0015631 | tubulin binding | 4 | 1 |
GO:0016879 | ligase activity, forming carbon-nitrogen bonds | 3 | 3 |
GO:0016881 | acid-amino acid ligase activity | 4 | 3 |
GO:0070739 | protein-glutamic acid ligase activity | 3 | 1 |
GO:0070740 | tubulin-glutamic acid ligase activity | 4 | 1 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 3 |
GO:0004835 | tubulin-tyrosine ligase activity | 3 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 143 | 145 | PF00675 | 0.264 |
CLV_NRD_NRD_1 | 150 | 152 | PF00675 | 0.264 |
CLV_NRD_NRD_1 | 210 | 212 | PF00675 | 0.322 |
CLV_NRD_NRD_1 | 256 | 258 | PF00675 | 0.327 |
CLV_NRD_NRD_1 | 277 | 279 | PF00675 | 0.284 |
CLV_NRD_NRD_1 | 298 | 300 | PF00675 | 0.598 |
CLV_NRD_NRD_1 | 435 | 437 | PF00675 | 0.337 |
CLV_NRD_NRD_1 | 454 | 456 | PF00675 | 0.256 |
CLV_NRD_NRD_1 | 571 | 573 | PF00675 | 0.471 |
CLV_NRD_NRD_1 | 614 | 616 | PF00675 | 0.529 |
CLV_PCSK_FUR_1 | 165 | 169 | PF00082 | 0.272 |
CLV_PCSK_FUR_1 | 433 | 437 | PF00082 | 0.333 |
CLV_PCSK_KEX2_1 | 150 | 152 | PF00082 | 0.270 |
CLV_PCSK_KEX2_1 | 167 | 169 | PF00082 | 0.298 |
CLV_PCSK_KEX2_1 | 21 | 23 | PF00082 | 0.745 |
CLV_PCSK_KEX2_1 | 210 | 212 | PF00082 | 0.322 |
CLV_PCSK_KEX2_1 | 256 | 258 | PF00082 | 0.334 |
CLV_PCSK_KEX2_1 | 260 | 262 | PF00082 | 0.314 |
CLV_PCSK_KEX2_1 | 298 | 300 | PF00082 | 0.597 |
CLV_PCSK_KEX2_1 | 435 | 437 | PF00082 | 0.358 |
CLV_PCSK_KEX2_1 | 454 | 456 | PF00082 | 0.249 |
CLV_PCSK_KEX2_1 | 571 | 573 | PF00082 | 0.471 |
CLV_PCSK_KEX2_1 | 614 | 616 | PF00082 | 0.529 |
CLV_PCSK_PC1ET2_1 | 167 | 169 | PF00082 | 0.330 |
CLV_PCSK_PC1ET2_1 | 21 | 23 | PF00082 | 0.745 |
CLV_PCSK_PC1ET2_1 | 260 | 262 | PF00082 | 0.327 |
CLV_PCSK_PC7_1 | 256 | 262 | PF00082 | 0.327 |
CLV_PCSK_PC7_1 | 294 | 300 | PF00082 | 0.491 |
CLV_PCSK_SKI1_1 | 102 | 106 | PF00082 | 0.538 |
CLV_PCSK_SKI1_1 | 144 | 148 | PF00082 | 0.227 |
CLV_PCSK_SKI1_1 | 224 | 228 | PF00082 | 0.320 |
CLV_PCSK_SKI1_1 | 271 | 275 | PF00082 | 0.327 |
CLV_PCSK_SKI1_1 | 365 | 369 | PF00082 | 0.327 |
CLV_PCSK_SKI1_1 | 571 | 575 | PF00082 | 0.444 |
CLV_Separin_Metazoa | 451 | 455 | PF03568 | 0.367 |
DEG_APCC_DBOX_1 | 12 | 20 | PF00400 | 0.510 |
DEG_APCC_DBOX_1 | 340 | 348 | PF00400 | 0.498 |
DEG_Nend_UBRbox_4 | 1 | 3 | PF02207 | 0.445 |
DOC_CKS1_1 | 103 | 108 | PF01111 | 0.427 |
DOC_CYCLIN_RxL_1 | 184 | 192 | PF00134 | 0.428 |
DOC_CYCLIN_yCln2_LP_2 | 191 | 197 | PF00134 | 0.458 |
DOC_CYCLIN_yCln2_LP_2 | 378 | 384 | PF00134 | 0.343 |
DOC_MAPK_DCC_7 | 484 | 493 | PF00069 | 0.527 |
DOC_MAPK_gen_1 | 11 | 19 | PF00069 | 0.506 |
DOC_MAPK_gen_1 | 256 | 267 | PF00069 | 0.499 |
DOC_MAPK_gen_1 | 278 | 286 | PF00069 | 0.482 |
DOC_MAPK_MEF2A_6 | 260 | 269 | PF00069 | 0.477 |
DOC_MAPK_MEF2A_6 | 278 | 286 | PF00069 | 0.353 |
DOC_MAPK_MEF2A_6 | 330 | 339 | PF00069 | 0.308 |
DOC_MAPK_NFAT4_5 | 279 | 287 | PF00069 | 0.458 |
DOC_PP1_RVXF_1 | 143 | 150 | PF00149 | 0.436 |
DOC_PP1_RVXF_1 | 222 | 229 | PF00149 | 0.458 |
DOC_PP1_RVXF_1 | 71 | 78 | PF00149 | 0.440 |
DOC_PP2B_LxvP_1 | 191 | 194 | PF13499 | 0.458 |
DOC_PP2B_LxvP_1 | 378 | 381 | PF13499 | 0.425 |
DOC_PP2B_LxvP_1 | 425 | 428 | PF13499 | 0.368 |
DOC_USP7_MATH_1 | 217 | 221 | PF00917 | 0.566 |
DOC_USP7_MATH_1 | 304 | 308 | PF00917 | 0.685 |
DOC_USP7_MATH_1 | 41 | 45 | PF00917 | 0.749 |
DOC_USP7_MATH_1 | 417 | 421 | PF00917 | 0.487 |
DOC_USP7_MATH_1 | 510 | 514 | PF00917 | 0.543 |
DOC_WW_Pin1_4 | 1 | 6 | PF00397 | 0.469 |
DOC_WW_Pin1_4 | 102 | 107 | PF00397 | 0.569 |
DOC_WW_Pin1_4 | 215 | 220 | PF00397 | 0.533 |
DOC_WW_Pin1_4 | 243 | 248 | PF00397 | 0.438 |
DOC_WW_Pin1_4 | 300 | 305 | PF00397 | 0.747 |
DOC_WW_Pin1_4 | 394 | 399 | PF00397 | 0.562 |
DOC_WW_Pin1_4 | 495 | 500 | PF00397 | 0.416 |
DOC_WW_Pin1_4 | 96 | 101 | PF00397 | 0.454 |
LIG_14-3-3_CanoR_1 | 242 | 247 | PF00244 | 0.527 |
LIG_14-3-3_CanoR_1 | 298 | 304 | PF00244 | 0.613 |
LIG_14-3-3_CanoR_1 | 374 | 379 | PF00244 | 0.506 |
LIG_14-3-3_CanoR_1 | 433 | 439 | PF00244 | 0.354 |
LIG_Actin_WH2_2 | 470 | 486 | PF00022 | 0.474 |
LIG_Actin_WH2_2 | 504 | 519 | PF00022 | 0.495 |
LIG_APCC_ABBA_1 | 265 | 270 | PF00400 | 0.527 |
LIG_APCC_ABBA_1 | 337 | 342 | PF00400 | 0.464 |
LIG_Clathr_ClatBox_1 | 476 | 480 | PF01394 | 0.464 |
LIG_eIF4E_1 | 268 | 274 | PF01652 | 0.525 |
LIG_EVH1_2 | 88 | 92 | PF00568 | 0.385 |
LIG_FHA_1 | 373 | 379 | PF00498 | 0.565 |
LIG_FHA_1 | 441 | 447 | PF00498 | 0.490 |
LIG_FHA_1 | 517 | 523 | PF00498 | 0.527 |
LIG_FHA_1 | 584 | 590 | PF00498 | 0.642 |
LIG_FHA_2 | 232 | 238 | PF00498 | 0.527 |
LIG_FHA_2 | 243 | 249 | PF00498 | 0.455 |
LIG_FHA_2 | 250 | 256 | PF00498 | 0.365 |
LIG_FHA_2 | 503 | 509 | PF00498 | 0.467 |
LIG_FHA_2 | 561 | 567 | PF00498 | 0.574 |
LIG_FHA_2 | 76 | 82 | PF00498 | 0.571 |
LIG_LIR_Gen_1 | 186 | 195 | PF02991 | 0.552 |
LIG_LIR_Gen_1 | 196 | 203 | PF02991 | 0.492 |
LIG_LIR_Gen_1 | 472 | 482 | PF02991 | 0.529 |
LIG_LIR_Gen_1 | 62 | 72 | PF02991 | 0.364 |
LIG_LIR_Nem_3 | 186 | 191 | PF02991 | 0.552 |
LIG_LIR_Nem_3 | 196 | 200 | PF02991 | 0.492 |
LIG_LIR_Nem_3 | 472 | 477 | PF02991 | 0.458 |
LIG_LIR_Nem_3 | 518 | 523 | PF02991 | 0.434 |
LIG_LIR_Nem_3 | 62 | 68 | PF02991 | 0.365 |
LIG_LIR_Nem_3 | 76 | 80 | PF02991 | 0.436 |
LIG_NRBOX | 283 | 289 | PF00104 | 0.458 |
LIG_REV1ctd_RIR_1 | 225 | 231 | PF16727 | 0.467 |
LIG_SH2_CRK | 130 | 134 | PF00017 | 0.550 |
LIG_SH2_CRK | 352 | 356 | PF00017 | 0.425 |
LIG_SH2_CRK | 65 | 69 | PF00017 | 0.300 |
LIG_SH2_GRB2like | 322 | 325 | PF00017 | 0.481 |
LIG_SH2_NCK_1 | 352 | 356 | PF00017 | 0.425 |
LIG_SH2_PTP2 | 285 | 288 | PF00017 | 0.504 |
LIG_SH2_SRC | 379 | 382 | PF00017 | 0.419 |
LIG_SH2_STAP1 | 540 | 544 | PF00017 | 0.415 |
LIG_SH2_STAT5 | 268 | 271 | PF00017 | 0.466 |
LIG_SH2_STAT5 | 285 | 288 | PF00017 | 0.464 |
LIG_SH2_STAT5 | 338 | 341 | PF00017 | 0.518 |
LIG_SH2_STAT5 | 379 | 382 | PF00017 | 0.419 |
LIG_SH3_3 | 100 | 106 | PF00018 | 0.500 |
LIG_SH3_3 | 266 | 272 | PF00018 | 0.436 |
LIG_SH3_3 | 37 | 43 | PF00018 | 0.524 |
LIG_SH3_3 | 395 | 401 | PF00018 | 0.567 |
LIG_SUMO_SIM_anti_2 | 443 | 448 | PF11976 | 0.317 |
LIG_SUMO_SIM_par_1 | 285 | 291 | PF11976 | 0.537 |
LIG_SUMO_SIM_par_1 | 442 | 448 | PF11976 | 0.275 |
LIG_SUMO_SIM_par_1 | 608 | 613 | PF11976 | 0.390 |
LIG_TRAF2_1 | 25 | 28 | PF00917 | 0.498 |
LIG_TYR_ITSM | 61 | 68 | PF00017 | 0.352 |
LIG_WRC_WIRS_1 | 418 | 423 | PF05994 | 0.451 |
MOD_CDC14_SPxK_1 | 99 | 102 | PF00782 | 0.503 |
MOD_CDK_SPxK_1 | 96 | 102 | PF00069 | 0.465 |
MOD_CK1_1 | 196 | 202 | PF00069 | 0.429 |
MOD_CK1_1 | 218 | 224 | PF00069 | 0.377 |
MOD_CK1_1 | 297 | 303 | PF00069 | 0.700 |
MOD_CK1_1 | 323 | 329 | PF00069 | 0.501 |
MOD_CK1_1 | 96 | 102 | PF00069 | 0.578 |
MOD_CK2_1 | 180 | 186 | PF00069 | 0.569 |
MOD_CK2_1 | 231 | 237 | PF00069 | 0.563 |
MOD_CK2_1 | 242 | 248 | PF00069 | 0.475 |
MOD_CK2_1 | 249 | 255 | PF00069 | 0.379 |
MOD_CK2_1 | 417 | 423 | PF00069 | 0.475 |
MOD_CK2_1 | 434 | 440 | PF00069 | 0.384 |
MOD_CK2_1 | 445 | 451 | PF00069 | 0.305 |
MOD_CK2_1 | 469 | 475 | PF00069 | 0.458 |
MOD_CK2_1 | 560 | 566 | PF00069 | 0.370 |
MOD_CK2_1 | 79 | 85 | PF00069 | 0.604 |
MOD_Cter_Amidation | 276 | 279 | PF01082 | 0.325 |
MOD_DYRK1A_RPxSP_1 | 102 | 106 | PF00069 | 0.465 |
MOD_GlcNHglycan | 159 | 162 | PF01048 | 0.296 |
MOD_GlcNHglycan | 43 | 46 | PF01048 | 0.724 |
MOD_GlcNHglycan | 447 | 450 | PF01048 | 0.281 |
MOD_GlcNHglycan | 51 | 55 | PF01048 | 0.602 |
MOD_GlcNHglycan | 512 | 515 | PF01048 | 0.289 |
MOD_GlcNHglycan | 577 | 580 | PF01048 | 0.495 |
MOD_GSK3_1 | 115 | 122 | PF00069 | 0.415 |
MOD_GSK3_1 | 153 | 160 | PF00069 | 0.503 |
MOD_GSK3_1 | 189 | 196 | PF00069 | 0.443 |
MOD_GSK3_1 | 294 | 301 | PF00069 | 0.637 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.514 |
MOD_GSK3_1 | 318 | 325 | PF00069 | 0.629 |
MOD_GSK3_1 | 361 | 368 | PF00069 | 0.504 |
MOD_GSK3_1 | 407 | 414 | PF00069 | 0.520 |
MOD_GSK3_1 | 417 | 424 | PF00069 | 0.466 |
MOD_GSK3_1 | 75 | 82 | PF00069 | 0.447 |
MOD_N-GLC_1 | 318 | 323 | PF02516 | 0.679 |
MOD_N-GLC_1 | 372 | 377 | PF02516 | 0.299 |
MOD_N-GLC_1 | 495 | 500 | PF02516 | 0.225 |
MOD_NEK2_1 | 153 | 158 | PF00069 | 0.482 |
MOD_NEK2_1 | 189 | 194 | PF00069 | 0.515 |
MOD_NEK2_1 | 288 | 293 | PF00069 | 0.459 |
MOD_NEK2_1 | 421 | 426 | PF00069 | 0.497 |
MOD_NEK2_1 | 502 | 507 | PF00069 | 0.436 |
MOD_NEK2_1 | 516 | 521 | PF00069 | 0.436 |
MOD_NEK2_1 | 522 | 527 | PF00069 | 0.333 |
MOD_NEK2_1 | 560 | 565 | PF00069 | 0.523 |
MOD_PKA_1 | 298 | 304 | PF00069 | 0.613 |
MOD_PKA_2 | 241 | 247 | PF00069 | 0.527 |
MOD_PKA_2 | 297 | 303 | PF00069 | 0.600 |
MOD_PKA_2 | 373 | 379 | PF00069 | 0.444 |
MOD_PKA_2 | 434 | 440 | PF00069 | 0.313 |
MOD_PKA_2 | 516 | 522 | PF00069 | 0.491 |
MOD_PKA_2 | 560 | 566 | PF00069 | 0.550 |
MOD_PKA_2 | 60 | 66 | PF00069 | 0.384 |
MOD_Plk_1 | 115 | 121 | PF00069 | 0.352 |
MOD_Plk_1 | 181 | 187 | PF00069 | 0.428 |
MOD_Plk_1 | 318 | 324 | PF00069 | 0.516 |
MOD_Plk_1 | 75 | 81 | PF00069 | 0.566 |
MOD_Plk_2-3 | 81 | 87 | PF00069 | 0.559 |
MOD_Plk_4 | 115 | 121 | PF00069 | 0.404 |
MOD_Plk_4 | 374 | 380 | PF00069 | 0.458 |
MOD_Plk_4 | 417 | 423 | PF00069 | 0.469 |
MOD_Plk_4 | 442 | 448 | PF00069 | 0.336 |
MOD_Plk_4 | 497 | 503 | PF00069 | 0.425 |
MOD_ProDKin_1 | 1 | 7 | PF00069 | 0.465 |
MOD_ProDKin_1 | 215 | 221 | PF00069 | 0.533 |
MOD_ProDKin_1 | 243 | 249 | PF00069 | 0.438 |
MOD_ProDKin_1 | 300 | 306 | PF00069 | 0.747 |
MOD_ProDKin_1 | 394 | 400 | PF00069 | 0.558 |
MOD_ProDKin_1 | 495 | 501 | PF00069 | 0.416 |
MOD_ProDKin_1 | 96 | 102 | PF00069 | 0.465 |
MOD_SUMO_rev_2 | 541 | 550 | PF00179 | 0.436 |
TRG_DiLeu_BaEn_3 | 553 | 559 | PF01217 | 0.360 |
TRG_DiLeu_BaLyEn_6 | 269 | 274 | PF01217 | 0.525 |
TRG_DiLeu_BaLyEn_6 | 518 | 523 | PF01217 | 0.449 |
TRG_DiLeu_BaLyEn_6 | 569 | 574 | PF01217 | 0.472 |
TRG_ENDOCYTIC_2 | 130 | 133 | PF00928 | 0.528 |
TRG_ENDOCYTIC_2 | 136 | 139 | PF00928 | 0.520 |
TRG_ENDOCYTIC_2 | 285 | 288 | PF00928 | 0.464 |
TRG_ENDOCYTIC_2 | 65 | 68 | PF00928 | 0.326 |
TRG_ER_diArg_1 | 120 | 123 | PF00400 | 0.380 |
TRG_ER_diArg_1 | 149 | 151 | PF00400 | 0.507 |
TRG_ER_diArg_1 | 209 | 211 | PF00400 | 0.522 |
TRG_ER_diArg_1 | 432 | 435 | PF00400 | 0.391 |
TRG_ER_diArg_1 | 453 | 455 | PF00400 | 0.425 |
TRG_ER_diArg_1 | 570 | 572 | PF00400 | 0.468 |
TRG_ER_diArg_1 | 614 | 616 | PF00400 | 0.424 |
TRG_NES_CRM1_1 | 440 | 456 | PF08389 | 0.344 |
TRG_Pf-PMV_PEXEL_1 | 150 | 154 | PF00026 | 0.303 |
TRG_Pf-PMV_PEXEL_1 | 211 | 215 | PF00026 | 0.244 |
TRG_Pf-PMV_PEXEL_1 | 436 | 440 | PF00026 | 0.450 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IAP5 | Leptomonas seymouri | 25% | 83% |
A0A0N1IH77 | Leptomonas seymouri | 56% | 100% |
A0A0S4J7C9 | Bodo saltans | 25% | 93% |
A0A0S4JH38 | Bodo saltans | 33% | 100% |
A0A0S4KQK8 | Bodo saltans | 26% | 94% |
A0A1X0P0Y5 | Trypanosomatidae | 37% | 100% |
A0A1X0P6A0 | Trypanosomatidae | 26% | 93% |
A0A3Q8IDL7 | Leishmania donovani | 24% | 100% |
A0A3Q8III2 | Leishmania donovani | 27% | 85% |
A0A422N064 | Trypanosoma rangeli | 42% | 100% |
A0A422N932 | Trypanosoma rangeli | 25% | 100% |
A0A422P136 | Trypanosoma rangeli | 25% | 94% |
A4HH59 | Leishmania braziliensis | 76% | 100% |
A4HYN9 | Leishmania infantum | 24% | 100% |
A4I479 | Leishmania infantum | 100% | 100% |
A4IC28 | Leishmania infantum | 27% | 85% |
A4Q9E8 | Mus musculus | 26% | 75% |
A4Q9F6 | Mus musculus | 24% | 77% |
A6NNM8 | Homo sapiens | 25% | 76% |
A8CVX7 | Danio rerio | 27% | 79% |
B6DTF7 | Bodo saltans | 22% | 100% |
C9ZI96 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 25% | 90% |
C9ZKP9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 100% |
C9ZPR8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 25% | 100% |
C9ZYH1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 94% |
D0A044 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 22% | 100% |
E9ADM8 | Leishmania major | 93% | 100% |
E9AFW7 | Leishmania major | 26% | 85% |
E9AID0 | Leishmania braziliensis | 25% | 100% |
E9AM52 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
E9B720 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 85% |
Q8N841 | Homo sapiens | 25% | 73% |
V5ARK1 | Trypanosoma cruzi | 26% | 100% |
V5B4U2 | Trypanosoma cruzi | 42% | 100% |